Nancy Driscoll

469 total citations
9 papers, 340 citations indexed

About

Nancy Driscoll is a scholar working on Genetics, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Nancy Driscoll has authored 9 papers receiving a total of 340 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 4 papers in Pathology and Forensic Medicine and 3 papers in Immunology. Recurrent topics in Nancy Driscoll's work include Chronic Lymphocytic Leukemia Research (6 papers), Lymphoma Diagnosis and Treatment (4 papers) and Immunodeficiency and Autoimmune Disorders (3 papers). Nancy Driscoll is often cited by papers focused on Chronic Lymphocytic Leukemia Research (6 papers), Lymphoma Diagnosis and Treatment (4 papers) and Immunodeficiency and Autoimmune Disorders (3 papers). Nancy Driscoll collaborates with scholars based in United States. Nancy Driscoll's co-authors include D. Janson, Shimaa A. Ahmed, Nitin Gupta, KR Rai, Darsh Patel, R. Kanti, Timothy S. Larson, Scott L. Nyberg, Mark D. Stegall and Dilip Patel and has published in prestigious journals such as Blood, Journal of Dairy Science and Transplantation.

In The Last Decade

Nancy Driscoll

9 papers receiving 330 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nancy Driscoll United States	7	158	121	104	96	89	9	340
M Hourmant France	9	14 0.1×	41 0.3×	42 0.4×	10 0.1×	55 0.6×	22	294
J.M. Korach France	10	60 0.4×	13 0.1×	179 1.7×	98 1.0×	16 0.2×	22	301
Marian Dynis United States	8	73 0.5×	58 0.5×	31 0.3×	172 1.8×	13 0.1×	13	400
F. Egidi United States	10	12 0.1×	25 0.2×	38 0.4×	56 0.6×	24 0.3×	23	292
TE Starzl United States	7	11 0.1×	24 0.2×	51 0.5×	47 0.5×	41 0.5×	20	276
Durjoy K. Shome Bahrain	10	101 0.6×	20 0.2×	44 0.4×	168 1.8×	21 0.2×	33	264
Mamta Puraswani India	9	43 0.3×	15 0.1×	62 0.6×	47 0.5×	48 0.5×	15	232
R Arrieta Spain	10	80 0.5×	39 0.3×	18 0.2×	188 2.0×	9 0.1×	17	264
Savaş Kansoy Türkiye	10	56 0.4×	21 0.2×	43 0.4×	55 0.6×	25 0.3×	18	219
M. Webb United States	11	24 0.2×	34 0.3×	52 0.5×	77 0.8×	24 0.3×	26	413

Countries citing papers authored by Nancy Driscoll

Since Specialization

Citations

This map shows the geographic impact of Nancy Driscoll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy Driscoll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy Driscoll more than expected).

Fields of papers citing papers by Nancy Driscoll

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nancy Driscoll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy Driscoll. The network helps show where Nancy Driscoll may publish in the future.

Co-authorship network of co-authors of Nancy Driscoll

This figure shows the co-authorship network connecting the top 25 collaborators of Nancy Driscoll. A scholar is included among the top collaborators of Nancy Driscoll based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nancy Driscoll. Nancy Driscoll is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Driscoll, Nancy. (2016). Idelalisib: Practical Tools for Identifying and Managing Adverse Events in Clinical Practice. Journal of the Advanced Practitioner in Oncology. 7(6). 604–613. 2 indexed citations

2.

Barrientos, Jacqueline C., et al.. (2015). Outcomes of Patients with Chronic Lymphocytic Leukemia (CLL) after Idelalisib Therapy Discontinuation. Blood. 126(23). 4155–4155. 8 indexed citations

3.

Kaufman, Matthew, D. Janson, Nancy Driscoll, et al.. (2010). Alemtuzumab maintenance may safely prolong chemotherapy-free intervals in chronic lymphocytic leukemia. Medical Oncology. 28(2). 532–538. 7 indexed citations

4.

Kaufman, Matthew, Sewanti Limaye, Nancy Driscoll, et al.. (2009). A combination of rituximab, cyclophosphamide and dexamethasone effectively treats immune cytopenias of chronic lymphocytic leukemia. Leukemia & lymphoma. 50(6). 892–899. 61 indexed citations

5.

Textor, Stephen C., Sandra J. Taler, Nancy Driscoll, et al.. (2005). Blood Pressure and Renal Function after Kidney Donation from Hypertensive Living Donors. Transplantation. 79(12). 1769–1770. 3 indexed citations

6.

Kanti, R., Tarun Wasil, Nancy Driscoll, et al.. (2004). Clinical staging and prognostic markers in chronic lymphocytic leukemia. Hematology/Oncology Clinics of North America. 18(4). 795–805. 24 indexed citations

7.

Textor, Stephen C., Sandra J. Taler, Nancy Driscoll, et al.. (2004). Blood Pressure and Renal Function after Kidney Donation from Hypertensive Living Donors. Transplantation. 78(2). 276–282. 116 indexed citations

8.

Gupta, Nitin, Darsh Patel, D. Janson, et al.. (2002). Rituximab-based chemotherapy for steroid-refractory autoimmune hemolytic anemia of chronic lymphocytic leukemia. Leukemia. 16(10). 2092–2095. 103 indexed citations

9.

Driscoll, Nancy, Charlotte Brennand, & Deloy G. Hendricks. (1985). Sensory Quality of Nonfat Dry Milk after Long-Term Storage. Journal of Dairy Science. 68(8). 1931–1935. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact